The next generation of alginate dressings: recent innovations for chronic wound healing Authors: Eduarda Pinto, Cristina C Barrias, Judite Novais Barbosa Published: 2026 ABSTRACT AbstractChronic wounds remain a major clinical challenge with a huge associated socioeconomic burden. Therefore, multifunctional biomaterials that can simultaneously manage exudate, modulate inflammation, prevent infection and promote tissue regeneration are extremely needed. Alginate, a naturally derived and highly biocompatible polysaccharide, has long been used in the clinic for advanced wound care due to its intrinsic gel-forming ability and capacity to maintain a moist healing environment. However, commercially available products are primarily designed to absorb exudate and physically protect the wound, while offering limited support for other key therapeutic goals, including modulation of inflammation and stimulation of tissue repair and regeneration. This review highlights the most recent innovations aimed at enhancing alginate’s therapeutic potential, either through physicochemical modifications of hydrogels or by expanding beyond traditional hydrogel formats into novel alginate architectures that offer improved tissue integration, tunability and controlled release of substances. The review also outlines synergistic formulations combining alginate with other biomaterials, bioactive molecules and cell-derived products to enhance its mechanical properties and antimicrobial performance, as well as to address immunomodulation and promote regeneration in chronic wounds. Together, these emerging approaches underscore alginate’s versatility and potential as a multifunctional platform for next-generation chronic wound therapies.Keywords: alginate, chronic wounds, bioengineering, regeneration, wound management Alginate Alginate is a naturally occurring biomaterial commonly used as a hydrogel for several biomedical applications, including wound healing. It can be extracted from brown algae and bacteria, with algae being the main source of commercially available alginates and, consequently, of most clinical-grade formulations [1]. Still, it is essential to ensure that the manufacturing and purification processes are appropriate for the intended application, as different purification levels are available and some preparations may contain residual contaminants and endotoxins [2–4]. Nonetheless, its natural origin, biodegradability and potential for sustainable sourcing and recycling characterize alginate as an environmentally friendly polymer [5]. This hydrophilic anionic polysaccharide is composed of (1,4)-linked α-L-guluronate (G) and β-D-mannuronate (M) residues arranged in homopolymeric (GG and MM) and heteropolymeric (MG/GM) blocks (Figure 1). The ratio and sequential distribution of G and M units vary depending on the alginate source and determine its chemical, physical and biological properties [8, 9]. In addition, the high density of hydroxyl (–OH) and carboxyl (–COOH) groups confers marked hydrophilicity and water absorption capacity, which are essential for maintaining a moist wound environment [10]. For biomedical applications, alginate hydrogels are typically prepared as 0.5–3% (w/v) alginate solutions through ionic gelation with divalent cations (Ca2+, Ba2+ or Mg2+) [11]. The most widely used approach is external gelation, in which alginate solutions or pre-formed dressings are exposed to calcium chloride (CaCl2) baths or sprays, leading to rapid crosslinking at the surface and the formation of mechanically robust hydrogels [12]. In contrast, internal gelation, commonly achieved using calcium carbonate (CaCO3) and glucono-δ-lactone (GDL), allows the gradual release of Ca2+ ions and the formation of more structurally uniform but generally softer hydrogels [13]. In both approaches, Ca2+ ions interact preferentially with G-blocks to create the so-called ‘egg-box’ structure, generating a crosslinked network (Figure 1). Although ionic crosslinking is the most prevalent method, gelation can also be achieved through several other strategies, including covalent crosslinking using glutaraldehyde or polyethylene glycol diacrylate (PEGDA), Schiff base reaction, photo crosslinking and thermal crosslinking [14]. Schematic representation of alginate monomers, namely α-L-guluronate (G) and β-D-mannuronate (M), and ionically crosslinked alginate (e.g. with calcium ions). Adapted from [6] and [7], created with ‘BioRender.com’. Biocompatible characteristics Taking into account that alginate is abundantly available in nature and highly biocompatible, it has been widely used as a biomaterial in several fields, not only in medical applications but also in cosmetics, bioremediation and the food industry. Alginate-based products are generally recognized as safe (GRAS) and are approved by the Food and Drug Administration (FDA) for specific uses [8]. For wound healing applications, the main advantage of alginate is its ability to manage moderate-to-high exudate, together with its capacity to conform to irregularly shaped wounds [15]. It can also provide effective haemostasis in bleeding wounds by enhancing local clot formation and is generally considered non-immunogenic [1]. In addition, alginate hydrogels exhibit structural and biomechanical features that resemble certain aspects of the extracellular matrix (ECM), making them attractive scaffolds for cell embedding in a 3D environment. Furthermore, as will be discussed later in this review, alginate can be easily modified to tailor its mechanical, chemical and biological properties, thereby influencing cell behaviour and potentially improving wound closure [16]. Alginate hydrogels can also serve as drug delivery platforms, enabling controlled release profiles that can be adjusted according to specific applications [17]. For example, alginate hydrogels display pH-responsive behaviour: at higher pH values, such as those typically found in chronic wounds, deprotonation of carboxyl groups increases electrostatic repulsion within the polymer network, promoting swelling and the consequent release of loaded therapeutic agents [18, 19]. Conversely, at lower pH values, protonation reduces charge repulsion, leading to hydrogel shrinkage. Provided that these variations in ionization do not compromise the integrity of the polymer network, the swelling-shrinking process remains largely reversible, underscoring the versatility and functionality of alginate hydrogels [19]. Chronic wounds A wound typically undergoes a complex healing process comprising three main phases. First, an inflammatory phase begins with fibrin clot formation and proceeds to immune cell recruitment in response to the local release of cytokines, growth factors and damage-associated molecular patterns (DAMPs). Polymorphonuclear leukocytes (PMNs), macrophages and lymphocytes are initially responsible for the clearance of cellular debris and microorganisms, but later, PMNs exit the wound environment and macrophages switch to an M2, anti-inflammatory profile, which further induces re-epithelization by keratinocytes, stimulates fibroblast activity and promotes angiogenesis. At this point, a proliferative phase is initiated, and ECM assembly is essential to support cell migration, vascular network formation and ultimately wound closure. Finally, a remodelling phase occurs to enhance tissue integrity, mainly characterized by a conversion of previously secreted collagen type III fibres into organized type I fibres. A tightly regulated balance between matrix production and degradation is fundamental for the formation of a healthy scar and successful wound healing [20–22]. However, when a wound fails to progress through this sequence of phases and to close within an expected time frame, it is considered chronic and can ultimately lead to limb loss [23]. Chronic wounds usually remain trapped in the inflammatory phase and can be further classified as arterial, diabetic, pressure and venous ulcers according to their etiology [24]. Physiologically, chronic wounds are typically characterized by a persistent inflammatory state and an increased risk of infection, including the formation of antibiotic-resistant biofilms [25, 26]. Moreover, they are often associated with other underlying clinical conditions, such as diabetes, obesity, ageing and vascular insufficiency, that hinder repair progression and impair healing [20]. Due to their non-healing nature and constant need for care, chronic wounds negatively impact patients’ quality of life and represent a substantial socioeconomic burden [27]. Commercially available alginate-based products for chronic wound treatment The standard of care for chronic wounds primarily focuses on wound management rather than on the promotion of regeneration. Surgical debridement, meaning the surgical removal of non‐viable wound tissue, is frequently carried out, followed by antimicrobial treatment, when needed, and coverage of the wound with dressings that both protect the wound from external aggressions and absorb wound exudate [28, 29]. Taking into account their biocompatibility and high absorption capacity, alginate-based dressings have long been used in clinical wound care to manage heavy exudate [30], and examples of commercially available products can be found in Table 1. However, given the alginate bioinert nature, when used alone, it offers limited benefits for regeneration. In fact, evidence from systematic reviews and randomized controlled trials remains inconsistent, with several studies reporting no significant improvement in healing outcomes compared to alternative dressings, despite mentioning that there is a strong need for higher-quality clinical data [31–34]. This highlights the need for the development of advanced alginate-based products to improve clinical application and patient outcomes. Table 1Commercially available products for chronic wound management [1, 2, 30, 35, 36].NameCompanyCompositionKaltostat®ConvaTecCalcium and sodium alginateHyalogran®ConvaTecSodium alginate and hyaluronic acidComfeel®ColoplastCalcium alginate and sodium carboxymethyl celluloseBiatain®ColoplastAlginate and carboxymethyl cellulosePurilon Gel®ColoplastCalcium alginate and carboxymethyl celluloseSeaSorb®ColoplastCalcium alginateTegagen™3MSodium alginateFibracol™ Plus3MCalcium alginate and collagenNU-Derm™SystagenixSodium alginateSilvercel™SystagenixAlginate, carboxymethyl cellulose, nylon and silverAlgisite M®Smith+NephewCalcium alginateMelgisorb®MölnlyckeCalcium and sodium alginatePharma-Algi®PharmaplastCalcium and sodium alginateAlgostéril®BrothierCalcium alginateUrgosorb®UrgoCalcium and sodium alginate, carboxymethyl celluloseAlgicell® AgIntegraCalcium alginate and silverSorbsan®SorbsanCalcium alginateAlgivon®Advancis MedicalCalcium alginate and Manuka honey Commercially available products for chronic wound management [1, 2, 30, 35, 36]. Duciel et al. [2] evaluated in vitro the performance of six different commercially available alginate dressings and found that only Algostéril® was non-cytotoxic, maintaining 91% fibroblast viability. The authors also assessed calcium (Ca2+) release from the dressings and concluded that it depended on both the initial percentage of calcium content (as some of the dressings also contained sodium alginate in their composition) and the M/G ratio. Since Ca2+ binds preferentially and strongly to G-rich blocks, alginate dressings with a higher proportion of GG sequences exhibited lower Ca2+ release, while MM-rich alginate showed higher Ca2+ release [2]. This analysis is particularly relevant considering that, when applied to wounds, alginate dressings exchange Ca2+ ions with Na+ ions present in exudate and blood. The released Ca2+ plays a critical role in the wound healing process by regulating several cell functions, including cell proliferation, migration and phagocytosis, as well as ECM remodelling and angiogenesis [37–39]. Concerning exudate management, although some of the tested dressings contained highly absorbent components (such as carboxymethylcellulose, sodium alginate or M-rich blocks) capable of retaining the liquid within their fibres, Algostéril exhibited the highest draining capacity, likely due to the presence of numerous lobes on the fibre surface [2]. The same group had previously studied the effect of some of these commercially available dressings on dermal fibroblasts, one of the key cell types involved in wound healing, and confirmed that the tested alginate-based dressings stimulated fibroblast migration and proliferation. Moreover, unlike the other dressings, Algostéril® induced significant activation of transforming growth factor beta (TGF-β), leading to increased secretion of vascular endothelial growth factor (VEGF) and collagen [40]. They also tested the effect of Algosteril® and Biatain® on macrophage polarization and observed that both alginates promoted an M1 pro-inflammatory profile, with Algosteril® additionally enhancing the secretion of chemokine ligand 18 (CCL18) [41]. In fact, Wu et al. [42] concluded that even varying M/G ratios of alginate alone are sufficient to influence macrophage polarization. More precisely, in Cu-loaded alginate, higher M/G ratios were shown to induce migration and an M1-like phenotype, whereas lower M/G promoted a shift toward an M2-like profile. In an attempt to functionalize already existing commercial alginate dressings, Niculescu et al. [43] described a strategy to incorporate Zn2+ ions through direct ionic crosslinking on top of conventional alginate-coated dressings. Using this approach, they were able to maintain hydrogel integrity while increasing antimicrobial activity and significantly promoting wound closure and tissue regeneration in a rat burn model. These findings illustrate that even small modifications of alginate hydrogels can substantially improve their therapeutic performance in chronic wound management, with clear benefits for patients. The next generation of alginate-based dressings In recent decades, the standard of care for chronic wounds has not changed significantly, remaining restricted to conventional treatment options that focus primarily on debridement and exudate management, with limited attention to active stimulation of tissue repair [44]. Alginate-based products, with their inherent versatility and biocompatibility, remain uniquely positioned to drive the next generation of wound therapies. Adding to exudate management and wound protection, these innovative alginate-based wound therapies should encompass three main features, namely the ability to (1) control inflammation, (2) promote tissue regeneration and (3) minimize the risk of infection. Accordingly, the following sections review some of the most recent advances involving alginate in combination with other biomaterials and bioactive molecules in an attempt to transform it from a passive material into a multifunctional active therapeutic platform for chronic wound treatment. Chemical functionalization of alginate for enhanced performance Alginate is typically used as a hydrogel, a formulation that offers major advantages for wound management due to its ability to maintain adequate moisture, absorb excessive exudate and conform to irregular wound geometries. While these baseline properties already make alginate clinically useful, its lack of inherent cell-adhesive motifs and limited bioactivity constrain its performance in more demanding regenerative contexts. Consequently, chemical functionalization has emerged not merely as an enhancement but as a necessary strategy to transform alginate from a passive dressing into an instructive biomaterial. These modifications can serve very different purposes, ranging from the introduction of specific bioactive moieties to improve cell adhesion, drug retention and controlled release, to the modulation of mechanical properties, degradation rates, crosslinking density, or responsiveness to external stimuli [14, 16, 45]. Given the wide diversity of strategies reported in the literature, the following section highlights only selected representative examples that illustrate the potential of alginate chemical functionalization for wound healing applications. A schematic representation of some alginate chemical functionalization can be found in Figure 2. Schematic representation of the most common alginate physicochemical modifications. Created with ‘BioRender.com’. REDV, RGD and YIGSR, amino acid sequences; K, hydrophobic cyclooctyne groups; SPAAC, strain-promoted azide-alkyne cycloaddition; MMP, matrix metalloproteinase. Pierschbacher et al. [46] first described the importance of the arginine-glycine-aspartic acid sequence (Arg-Gly-Asp, RGD) for cell attachment and, since then, this small peptide has been widely incorporated into biomaterial-based strategies in a variety of applications [47]. In alginate hydrogels, RGD peptides can be conjugated to the alginate backbone through different techniques, including carbodiimide chemistry [48–50], Cu(I)-catalysed azide–alkyne cycloaddition (CuAAC), strain-promoted azide-alkyne cycloaddition (SPAAC) [51, 52], thiol-ene or thiol-maleimide reactions [53] and reductive amination [54], among others [16, 55]. Compared to unmodified alginate, RGD-functionalized hydrogels demonstrate markedly enhanced cell adhesion, spreading and proliferation. However, more recent studies suggest that single-peptide functionalization may be insufficient to fully recapitulate the complexity of the ECM. In this regard, combinatorial peptide approaches, such as the co-presentation of YIGSR and REDV as described by Yu et al. [56], appear more promising, as they better mimic the multifactorial signalling environment of native tissues and have shown synergistic improvements in angiogenesis and endothelial cell behaviour. These findings indicate that multi-ligand systems may represent a more advanced and biologically relevant direction and recent research on cell-matrix and cell-material interactions resulted in the identification of a variety of bioactive peptides that, when incorporated into biomaterials, modulate cell adhesion and behaviour, including their migration, differentiation and proliferation [57, 58]. Although not designed for wound treatment, Neves et al. [51] described a simple modification of the hydrophilic alginate backbone with hydrophobic cyclooctyne groups (Alg-K), which are highly reactive to azide-functionalized compounds, enabling the hydrogel functionalization with several molecules via SPAAC, a fast and cytocompatible click reaction that can be performed in the presence of cells. Moreover, they showed that the self-association between hydrophobic domains translated into the formation of internal microstructural features, creating a 3D topography that could be sensed by cells, which influenced their morphology and spatial distribution [51]. The same group further demonstrated the functionalization of Alg-K with both RGD peptides and a matrix metalloproteinase (MMP)-sensitive moiety through SPAAC chemistry, in order to promote dermal fibroblasts adhesion to the hydrogel and enable cell-driven enzymatic matrix remodelling, respectively [52]. Compared to Cu(I)-catalysed reactions, SPAAC avoids the use of potentially cytotoxic metal catalysts and offers higher specificity than carbodiimide chemistry, making it especially suitable for in situ or cell-encapsulating applications and increasingly viewed as more promising for clinical translation. For developing tunable biomaterials, Lueckgen et al. [59] oxidized the alginate polymer backbone and subsequently performed covalent crosslinking using norbornene-tetrazine click chemistry. Contrary to ionically crosslinked alginate, which can exhibit poor stability and uncontrolled dissolution, this approach yielded hydrogels with controlled degradation and mechanical properties, which were cell-compatible and susceptible to hydrolytic breakdown, making them suitable for applications requiring gradual material resorption, such as drug delivery or wound healing. In another strategy, Zare-Gachi et al. [60] evaluated the effect of different degrees of sulphation on freeze-dried calcium alginate scaffolds and observed that the highest degree of substitution tested (0.9) resulted in the greatest swelling ratio, although compromising its stability and mechanical integrity. In contrast, scaffolds with an intermediate degree of sulphation (0.5) displayed higher collagen density, a more uniform collagen distribution and lower levels of TGF-β expression, leading to superior outcomes in terms of wound healing in a diabetic mouse model. These studies highlight the broad potential of alginate chemical functionalization to tailor material properties and introduce specific biological cues. However, enhancing individual functionalities often involves trade-offs that are not always addressed. For example, modifications such as sulphation or oxidation can improve swelling or tunable degradation but may compromise mechanical stability, while increased chemical complexity can introduce toxicity risks, especially with catalysts (e.g. CuAAC) or reactive intermediates that may induce immunogenic responses, compromising the biomaterial’s biocompatibility. Therefore, more cytocompatible strategies, such as SPAAC reactions, should be employed, while a combination of alginate with other biomaterials may improve mechanical properties, as will be discussed later. It should be noted that the examples described above represent only a small fraction of the wide range of strategies that have been explored to functionalize and engineer alginate for biomedical applications. Beyond peptide conjugation, numerous approaches have been reported to tailor mechanical properties, degradation behaviour, crosslinking mechanisms and responsiveness to environmental cues. Comprehensive discussions of these diverse modification routes, including bioactive ligand incorporation, structural tuning and advanced crosslinking chemistries, can be found in several recent reviews [10, 12, 14, 16, 45, 61]. Different formulations of alginate for chronic wound therapies As different diseases and applications require different tissue engineering strategies, another major advantage of alginate is that its use is not restricted to hydrogels, and numerous alternative formulations have been described [6, 62–64]. Compared to standard hydrogels, these alternative formats often address key limitations such as excessive hydrophilicity, limited mechanical strength or lack of multifunctionality. However, their relative effectiveness depends strongly on how well they balance structural complexity with practical applicability. The gel-forming ability of alginate can be explored in combination with other materials to overcome one of alginate’s main drawbacks, its poor ability to retain hydrophobic drugs. Shafieiuon et al. [65] developed an emulsion gel using dialdehyde carboxymethyl cellulose and CaCO3 as crosslinkers via hemiacetal and ionic interactions. These ‘emulgels’ were able to encapsulate curcumin and deliver it into wounds, resulting in accelerated wound closure and reduced inflammation in vivo. While promising, their advantage lies primarily in drug encapsulation rather than structural innovation, making them less versatile than more advanced architectures. From a different perspective, Ji et al. [66] employed directional freeze-drying technology and exploited the electrostatic attraction between chitosan and alginate to fabricate an anisotropic aerogel whose aligned channels enabled wound exudate absorption up to 1292.5% of its own weight (Figure 4A), much higher than that of traditional dressings used in the clinic. Despite this high absorbency, the dressing retained favourable mechanical and biological properties, including antioxidant and antibacterial activities, and promoted wound healing in a diabetic mouse model. Lin et al. [67] developed an aerogel based on sodium alginate, chitosan, and calcium peroxide nanoparticles (NPs) capable of continuously releasing oxygen while absorbing wound exudate, thereby addressing hypoxia, which is a major barrier in diabetic wound healing, while simultaneously enhancing collagen deposition and re-epithelialization, contributing to wound repair. Using a distinct approach, da Silva et al. [68] produced a foam dressing composed of calcium alginate and bacterial-derived cellulose incorporating silver-containing graphene oxide NPs, which conferred antimicrobial properties and high exudate absorption capability. SEM images of combinations of alginate with different biomaterials, reproduced with permission. (A) cross and longitudinal directions of different areas of an anisotropic aerogel made of chitosan and sodium alginate (SA) [66]. (B) SA and gelatin (GE) hydrogel membranes with varying concentrations of a bimetallic zinc oxide: cerium oxide nanocomposite, namely 1% (SA-GE@I), 2.5% (SA-GE@II), and 5% (SA-GE@III) [90]. (C) Chitosan (CS), CS grafted with poly(MA-co-AA), grafted CS+SA [85]. (D) A hydrogel made of Fe3+, protocatechualdehyde, polyvinyl alcohol (PVA), and SA at different pH values [96]. (E) Calcium alginate microparticles with or without cellulose nanocrystals (CNC) and a cross-section of the clear core-shell structure of these microparticles (third image) [75]. (F) Matrix gel (MG) and drug-loaded gel (DG) microneedle patches [72]. (G) Alginate (Alg) hydrogel membrane incorporated with 45S5 bioglass (Alg-BG), Al2O3/TiO2 nanoparticles (Alg-BG(AT)) and doxycycline (Alg-BG(AT)-D) [98]. (H) Morphological and cross-sectional micrographs of a bilayered dressing composed of chitosan loaded with cerium oxide nanoparticles and a vancomycin-loaded alginate coating [89]. Although gel-like formulations have the advantage of easily adapting to wound topography, in some cases, a more defined structure with stronger mechanical properties may be required. Ding et al. [69] combined polyvinyl alcohol (PVA) with sodium alginate to produce a nanofiber dressing through electrospinning. The dressing was further loaded with shikonin, a natural compound derived from traditional Chinese medicinal plants. This formulation not only exhibited antibacterial and antioxidant properties in vitro but also enhanced re-epithelization and wound closure in a mouse model by promoting angiogenesis and reducing inflammation. Electrospinning is an interesting technique for the design of advanced wound healing dressings, since it enables the production of structurally robust dressings that better mimic the fibrous architecture of native ECM. However, it requires the combination of alginate with other polymers, such as PVA, since alginate alone is not readily electrospinnable [70]. Using a different strategy, Alakija et al. [71] produced a stretchable patch for chronic wound treatment based on sodium alginate hydrogel combined with a nanocomposite containing halloysite nanotubes coated with magnesium oxide and silicon nitride. This formulation was extensively characterized and demonstrated the ability to enhance fibroblast migration and proliferation, reduce bacterial activity and maintain high swelling capacity. These stretchable nanocomposite patches introduce additional functionality, such as mechanical resilience and enhanced cell stimulation, but their increased complexity may complicate large-scale production. Hou et al. [72] built a microneedle patch consisting of a needle-like drug-loading gel based on a sodium alginate and polyethylene glycol (PEG) bilayer. These microneedles were able to penetrate bacterial biofilms and effectively release bioactive molecules such as erythromycin, vaccarin and demethylsuberosin, which provided antibacterial and antioxidant effects, while also promoting angiogenesis and reducing inflammation. In addition, the incorporation of cyanidin, a pH-responsive pigment, enabled the patch to visually indicate the wound status according to pH, which directly correlates with infection levels. This microneedle patch stands out as a particularly innovative strategy, since, unlike conventional dressings, it combines both the active delivery of therapeutic agents directly in the wound bed and the diagnostic dimension of real-time monitoring of wound status. Multilayer dressings represent another promising approach for treating chronic wounds, as they can better mimic the skin’s layered structure and provide multifunctionality. Notably, Latiyan et al. [73] designed a fibro-porous bilayer dressing composed of a lyophilized bottom layer of alginate, agarose and PVA, and an electrospun top layer of curdlan, agarose and PVA. Ciprofloxacin, a broad-spectrum antibiotic, was loaded in both layers, and the dressing demonstrated antibacterial activity, along with high swelling capacity, hemocompatibility and immunomodulatory effects. Moreover, the dressing exhibited minimal fibroblast adhesion, contributing to pain-free dressing changes. Ribeiro et al. [74] developed a three-layer dressing consisting of an outer layer of fibrous polycaprolactone (PCL) to protect the wound from microorganisms, an intermediate sodium alginate layer incorporating ampicillin, and an inner PCL/PEG layer designed to prevent wound adhesion and facilitate dressing exchange. This sandwich-like biomaterial showed mechanical integrity over time, high amounts of exudate absorption and controlled antibiotic release, resulting in antibacterial activity in vitro. Nevertheless, further in vitro and in vivo studies are still required to fully confirm its potential for wound treatment. Compared to single-layer systems, bilayer and trilayer constructs enable the spatial separation of functions, such as antimicrobial protection, exudate absorption and tissue interface optimization. However, despite their conceptual strength, their complexity may hinder translation unless manufacturing processes are streamlined. An alternative to planar architectures is the development of micro- and nanoscale systems, such as core–shell microparticles. Xu et al. [75] employed all-aqueous microfluidics to generate multifunctional microparticles composed of a calcium alginate and cellulose nanocrystals core loaded with epidermal growth factor (EGF), enclosed by a shell of alkylated chitosan, alginate and ciprofloxacin (Figure 4E). This design enabled the controlled, on-demand release of both the growth factor and the antibiotic, thereby supporting the wound healing process, while presenting antibacterial activity. Nevertheless, its clinical implementation may be limited by challenges in delivery and retention at the wound site. From a different angle, clay minerals have long been used in wound management due to their ability to stop bleeding and induce anti-inflammatory environments, along with their capacity to promote haemostasis, create an anti-inflammatory microenvironment and degrade into non-toxic products [76]. Since their combination with polymers often results in enhanced mechanical properties, Nomicisio et al. [77] created microspheres composed of alginate, chondroitin sulphate and layered double hydroxide (LDH), a synthetic clay with tunable chemical composition that can be gradually degraded through hydrolysis under acidic conditions, releasing its metal cations. Therefore, in this study, a zinc (Zn) and aluminium (Al)-based LDH was employed, which not only increased the stability of the microspheres in aqueous environments but also enabled the sustained release of bioactive Zn2+ ions into the wound. The authors reported enhanced cell proliferation in vitro and demonstrated the safety and efficacy of the biomaterial in vivo. Also focusing on metal ions, Saadatidizaji et al. [78] developed alginate hydrogel-based beads carrying curcumin, a molecule with anti-inflammatory properties, tetracycline hydrochloride, a widely used antibiotic and CuFe2O4 NPs to enable the release of Cu2+ cations, which exhibit antibacterial activity and pro-angiogenic effects. These nanocomposites proved to be pH- and temperature-responsive, with maximal release occurring at alkaline pH, commonly observed in chronic wounds and at higher temperatures, typically associated with infection [79]. Seeking more practical and minimally invasive formulations for clinic use, Liu et al. [80] developed a sprayable hydrogel composed of alginate and chitosan, in which the in situ generation of CO2 bubbles created a microporous structure. This system proved to be biocompatible, promoted coagulation and contributed to full wound closure in vivo. In a similar approach, Zhou et al. [81] produced a sprayable sodium alginate hydrogel that could be combined with a second spray containing a deep eutectic solvent and copper-tannic acid metal-polyphenol network, enabling rapid in situ crosslinking and direct application in vivo. In three different animal models, namely acute, infected and burn-infected skin wounds, this sprayable hydrogel promoted wound healing while exhibiting strong antibacterial effects. Shen et al. [82] also designed a sprayable low-oxidized sodium alginate grafting ε-polylysine hydrogel loaded with mesenchymal stem cell (MSC)-derived exosomes for topical application at skin graft donor sites to improve healing and prevent infection. By promoting local macrophage polarization toward an M2-like phenotype, the exosomes helped establish an anti-inflammatory environment that supported tissue repair. Compared to pre-formed dressings, sprayable systems allow rapid, minimally invasive application and excellent conformity to irregular wounds, positioning them among the most promising candidates for future clinical use. The wide variety of alginate-based formulations, from hydrogels and foams to multilayer and sprayable systems, summarized in Figure 3, demonstrates the material’s adaptability for chronic wound therapeutic needs. While each design targets specific functions such as exudate absorption, oxygen delivery or antimicrobial activity, conjugation of these functionalities and their influence on mechanical performance should be further explored to increase their clinical relevance. List of the different formulations of alginate. Created with ‘BioRender.com’. Combination with other materials Research efforts have also extensively focused on combining alginate with a range of complementary materials to overcome its intrinsic biological and mechanical limitations. For instance, chitosan, a polysaccharide derived from chitin, has long been combined with alginate to elevate the efficacy of natural hydrogel-based wound dressings. Due to their polycationic and polyanionic structures, respectively, chitosan and alginate can form stable polyelectrolyte complexes that improve exudate absorption capacity, drug release efficiency, mechanical properties [83] and antimicrobial activity [84]. For example, this was demonstrated by Raj et al. [85] who combined chitosan and sodium alginate to create a self-healing hydrogel with strong and prolonged antibiofilm activity, confirmed both in vitro and in vivo (Figure 4C). Ghodsi et al. [86] used alginate and chitosan to produce hydrogels containing niosomes, non-ionic surfactant-based vesicles structurally similar to liposomes, loaded with curcumin. This system enabled sustained curcumin release, resulting in improved cell viability and enhanced antibacterial properties. In a mouse model, a 90% decrease in wound size was achieved after 10 days, along with an increase in re-epithelization and collagen density and a decrease in inflammation. Specifically, MMP-2, MMP-13 and TGF-β were found to be upregulated, while interleukin (IL)-6, an inflammatory gene, was downregulated. In another approach, Johari et al. [87] investigated the effect of PEG, typically used as a surfactant for copper NPs added to chitosan/sodium alginate hydrogels. The presence of PEG improved degradation behaviour and swelling capacity through the formation of new intra- and intermolecular interactions within the composite, while also contributing to significant antibacterial activity due to a synergistic effect between chitosan and the copper NPs. Manoharan et al. [88] produced cerium oxide (CeO2) NPs that were subsequently encapsulated in a chitosan-alginate hydrogel. The resulting patch was shown to be cytocompatible and to have favourable mechanical properties and swelling capacity, critical features for moisture balance in wounds. Moreover, the cerium oxide conferred antioxidant and antibacterial activity, highlighting its potential for wound healing applications. Shahroudi et al. [89] further advanced this combinatory approach by first 3D-printing a chitosan matrix containing varying concentrations of CeO2 NPs, followed by coating the printed scaffold with an alginate layer loaded with vancomycin (Figure 4H). This approach yielded a structured and mechanically robust material based on chitosan, while the alginate coating enhanced NPs release. The dressing demonstrated antibacterial and antioxidant activity in vitro, along with confirmed cell biocompatibility. Iqbal et al. [90] also incorporated CeO2 NPs into a hydrogel composed of sodium alginate and gelatin instead of chitosan. In this case, CeO2 NPs were synthesized in combination with zinc oxide, forming a bimetallic nanocomposite that showed improved antioxidant and antibacterial activity (Figure 4B). While alginate/chitosan hydrogels are robust and relatively simple to implement systems, their functionality is often limited to passive antimicrobial and structural roles unless further modified. In turn, the incorporation of nanocarriers or nanoparticles offers superior control over drug delivery and wound microenvironment modulation, compared to basic polymer blends. Nevertheless, nanoparticle-based approaches raise concerns regarding long-term toxicity, accumulation and regulatory approval, meaning their clinical translation will depend on careful dose optimization. Alginate and gelatin constitute another attractive combination for wound healing applications. Unlike alginate and chitosan, gelatin inherently provides cell-binding motifs that support cell adhesion, migration and proliferation within the hydrogel, being more effective at promoting re-epithelization and wound closure [91]. Maikovych et al. [92] evaluated hydrogels consisting of alginate and gelatin covalently crosslinked using polyethylene glycol diglycidyl ether (PEGDE 500) and observed increased absorption capacity and enhanced resistance to enzymatic degradation, demonstrating their potential for effective exudate management. Similarly, Puri et al. [93] developed a lyophilized wafer consisting of 2% (w/v) calcium alginate and 1% (w/v) gelatin, which showed outstanding exudate absorption and strong antimicrobial activity in vitro due to increased linezolid release. Rizi et al. [94] further explored alginate-gelatin systems by incorporating 10 wt% royal jelly, a natural product rich in bioactive compounds, such as proteins, lipids, flavonoids and phenolic molecules with reported therapeutic potential in chronic wound management. The addition of royal jelly improved hydrogel swelling capacity and provided controlled degradation, while maintaining strong antibacterial activity and promoting tissue regeneration in full-thickness wounds in rats. Using a different strategy, Li et al. [95] developed an alginate hydrogel modified with aminophenylboronic acid (PBA) and PVA, incorporating tannic acid–ferric ion coordination nanospheres. Through dynamic interactions–including boronic ester bonds, hydrogen bonds and coordination bonds—a multifunctional hydrogel was obtained without the need for additional chemical or physical crosslinking. In a diabetic mouse model of infected full-thickness wounds, the material enhanced wound closure while reducing inflammation and vascular damage. The hydrogel also exhibited photothermal-, pH- and glucose-responsive behaviour. Zeng et al. [96] combined sodium alginate with protocatechualdehyde, PVA and Fe3+ to develop a multifunctional hydrogel that was skin-adhesive, self-healing and endowed with anti-inflammatory and antibacterial properties (Figure 4D). Compared to conventional covalently crosslinked hydrogels, these dynamical materials offer responsiveness to pathological conditions, such as infection or hyperglycaemia, being among the most versatile platforms currently available. Bioactive glasses also offer promising therapeutic potential in wound healing, as they can release biologically active ions that promote angiogenesis, modulate cellular behaviour and provide antibacterial and haemostatic effects [97]. As an example, Bargavi et al. [98] engineered a bioactive nanocomposite hydrogel membrane by combining an alginate hydrogel with a 45S5 bioactive glass containing titania (TiO2) and alumina (Al2O3) NPs (Figure 4G). In vitro, this biomaterial promoted collagen and VEGF expression and inhibited biofilm formation, while in vivo studies in zebrafish and rat models demonstrated enhanced re-epithelization and accelerated wound closure. Ortiz et al. [99] also included bioglass (54SiO2:40CaO:6P2O5) NPs and zinc oxide (ZnO) NPs in a sodium alginate and PVA mixture that was electrospun into a fibrous membrane. The bioglass NPs were essential to improve the fibres’ mechanical properties, and the final dressing proved to have antimicrobial activity and to be cytocompatible in vitro. Bioglass integration into alginate matrices results in materials that are both structurally stable and biologically instructive, but controlling ion release kinetics is critical to avoid cytotoxic effects. In a related strategy, Marinho et al. [100] used wet-spinning to produce coaxial fibres made of PCL and carbon nanofibers on the outer layer (shell) and sodium alginate loaded with ceftazidime on the inner layer (core) (Figure 4F). The inclusion of carbon nanofibers enhanced the flexibility and resilience of the composite, while also promoting blood clotting, whereas PCL contributed to reduced cytotoxicity. Nazemoroaia et al. [101] designed an asymmetric wound dressing comprising an upper layer of electrospun PCL-silk sericin and a lower chitosan-alginate hydrogel layer loaded with 10-hydroxydecanoic acid (queen bee acid). The hydrogel layer demonstrated high swelling capacity and 80% degradation after 14 days, favourable for early wound healing stages, whereas the top layer showed limited swelling and only 19% degradation, acting as an antibacterial barrier and conferring longer protection to the wound. This dressing was also tested in vivo in Wistar rats and demonstrated accelerated wound healing without inflammatory side effects. Using a similar bilayer concept, Gamal et al. [102] 3D-printed a bottom layer of sodium alginate/gelatin hydrogel incorporating pluronics nanomicelles loaded with either rutin, an antioxidant or simvastatin, an anti-inflammatory drug and assembled it with a top layer of electrospun PCL/cellulose acetate nanofibers enriched with chitosan/selenium NPs. This multifunctional bilayer wound dressing showed significant antibacterial activity in vitro, while also promoting wound healing in vivo in a diabetic rat model, including re-epithelization, collagen deposition, neovascularization and diminished inflammation. As mentioned before, hybrid fibre-based and multilayer systems enable spatial separation of functions, such as mechanical support, drug delivery and antimicrobial protection, also mimicking the hierarchical structure of skin. Therefore, these designs are particularly promising for chronic wounds, as they simultaneously address multiple healing requirements, including infection control, moisture balance and tissue regeneration. However, their increased structural complexity may pose challenges for large-scale manufacturing and cost-effectiveness. The above-mentioned strategies, summarized in Table 2, combine alginate with complementary materials such as chitosan, gelatin, bioactive glasses or nanoparticles, clearly integrating biological activity, controlled responsiveness and structural organization. In particular, dynamically crosslinked multifunctional hydrogels, bioactive glass-containing composites and multilayer or fibre-based architectures stand out as leading approaches, as they go beyond simple material reinforcement. However, the increasing compositional complexity of these systems raises concerns about reproducibility, scalability and clinical translation. Table 2Examples of alginate-based composite systems and their main effects on wound treatment.Composite systemOther biomaterials/molecules incorporatedMain results/effectsRef.Improved mechanical propertiesAntimicrobial & antioxidant activityIncreased absorption capacityImproved wound closureAlginate & Chitosan–XXXX[66]Calcium peroxide NPsXXXX[67]–X[80]–XX[85]Curcumin-loaded niosomesXX[86]PEG, copper NPsXXX[87]Cerium oxide NPsXXX[88]Cerium oxide NPs, vancomycinX[89]PCL, silk sericin, 10-hydroxydecanoic acidXXX[101]Alginate & GelatinCerium oxide NPs, zinc oxide NPsX[90]–XX[92]LinezolidXX[93]Royal jellyXXXX[94]PCL, cellulose acetate, chitosan, pluronics nanomicelles loaded with rutin or simvastatin, selenium NPsXX[102]Alginate & PVAShikoninXX[69]Agarose, curdlan, ciprofloxacinXX[73]PBA, tannic acid-ferric ion coordination nanospheresX[95]Fe3+, protocatechualdehydeX[96]Zinc oxide NPsXX[99]Alginate & PCLPEG, ampicillinXXX[74]Carbon nanofibers, ceftazidimeX[100]NPs, nanoparticles; PBA, aminophenylboronic acid; PCL, polycaprolactone; PEG, polyethylene glycol; PVA, polyvinyl alcohol. Examples of alginate-based composite systems and their main effects on wound treatment. NPs, nanoparticles; PBA, aminophenylboronic acid; PCL, polycaprolactone; PEG, polyethylene glycol; PVA, polyvinyl alcohol. Incorporation of bioactive molecules Chronic wounds present high susceptibility to infection, which often requires prolonged antibiotic administration. Therefore, the incorporation of antibiotics or other antimicrobial compounds into alginate-based dressings offers significant advantages for wound management, even when used as a prophylactic measure. For instance, Zorzi Bueno et al. [103] incorporated the broad-spectrum antibiotic gentamicin in alginate NPs, which were then loaded into chitosan-based films to achieve controlled antibiotic release over time. The incorporation of antibiotic-loaded NPs reduced the swelling of the film, thereby preventing an initial burst release of gentamicin, and providing a more sustained delivery profile compared to the direct incorporation of antibiotic alone. Moreover, drug release was shown to be pH-dependent, resulting in a more effective and responsive release under conditions relevant to infected wounds. Cao et al. [104] employed gelatin and sodium alginate to 3D-print a hydrogel loaded with ciprofloxacin hydrochloride. As predicted, the resultant construct showed outstanding antibacterial activity associated with a fast release of the antibiotic. In terms of wound treatment, the obtained dressing was only tested in vitro with a fibroblast cell line (L929) but revealed high biocompatibility and promotion of cell growth and migration. Bibire et al. [105] obtained similar results by incorporating rifampicin, another antibiotic, in alginate grafted with poly(N-vinylcaprolactam). However, taking into account that overconsumption and misuse of antibiotics have accelerated the development of antibiotic resistance and led to a global health crisis, there is an urgent need to find and implement effective alternative treatments [106]. In this context, Teixeira et al. [107] combined alginate and chitosan to produce a hydrogel loaded with grape pomace extracts. Since these extracts are rich in polyphenols and flavonoids, the formulation exhibited strong antioxidant capacity, along with antibacterial activity, highlighting its potential for wound healing applications. Xu et al. [108] produced poly (vinyl alcohol-co-ethylene) nanofibers and combined them with sodium alginate to produce aerogels that could be either sprayed to form aerogel films or moulded to form aerogel sponges. The film formulation showed high lysozyme adsorption capacity, while the sponge exhibited sustained lysozyme release over time. Given that lysozyme is a potent antimicrobial agent, its incorporation into these aerogel systems enhanced antibacterial performance, besides being non-cytotoxic and having adequate mechanical properties. Birca et al. [109] developed alginate hydrogels containing silver and tannylated calcium peroxide NPs, aiming to combine antimicrobial activity with controlled oxygen release. This approach enabled the mitigation of hypoxia typical of chronic wounds, providing a synergistic effect against bacterial biofilms. Nevertheless, on-demand strategies should be further explored to enable controlled delivery of antimicrobial molecules according to the specific needs of the wound [110]. To address this, Huang et al. [111] used 3D printing to develop a smart wound dressing based on alginate loaded with calcium phosphate NPs that enabled a pH-responsive degradation and drug release. More precisely, exposure to higher pH media accelerated dressing degradation, which in turn increased rhodamine B, bacitracin, and selenium NPs release, enhancing antimicrobial activity under the alkaline conditions typically found in chronic wounds. To achieve greater therapeutic efficacy, the incorporation of bioactive molecules into wound dressings should ideally address both antimicrobial activity and the regenerative/healing functions. For example, Da Silva et al. [112] loaded alginate hydrogels with human β-defensin-2, an antimicrobial peptide (AMP), aiming to improve the healing of methicillin-resistant Staphylococcus aureus (MRSA)-infected wounds. In a diabetic mouse model, the peptide reduced MRSA bacterial load and local inflammation, while enhancing cell proliferation and angiogenesis. In a related study, the same group reported a reduction in M1-like macrophages and reactive oxygen species (ROS), together with increased neovascularization and collagen deposition [113]. Bioactive peptides derived from the skin secretions of amphibians, such as RL-QN15, have also been described to accelerate wound healing [114, 115]. The same group that first identified this peptide has since then explored its potential, for example, by loading it inside hollow silica nanoparticles that were then incorporated inside Zn2+-crosslinked alginate [116]. The obtained hydrogel offered a slow release of RL-QN15, which resulted in enhanced re-epithelization with controlled angiogenesis and reduced inflammation, while also providing broad-spectrum antimicrobial activity. Compared to traditional antibiotics, these bioactive antimicrobial peptides offer a more holistic approach to wound healing, while reducing the risk of antibiotic resistance. On another perspective, nitric oxide (NO) plays a dual role as both an antimicrobial agent and a regulator of angiogenesis and inflammation. However, its clinical application is limited by its poor stability and short half-life. To overcome these challenges, Zhang et al. [117] synthesized S-nitrosoglutathione by combining NO with glutathione and subsequently loaded it into a thiolated alginate hydrogel to achieve controlled release. This system enabled a two-phase NO release: an initial high dose burst that enhanced antibacterial activity through bacterial DNA damage and metabolic disruption, followed by a lower sustained NO release that promoted angiogenesis. Similarly, Tan et al. [118] produced an alginate hydrogel loaded with S-nitrosoglutathione using a layer-by-layer melting-permeation crosslinking approach in which one of the layers had a sparser structure to accommodate wound exudates and delay NO release. This hydrogel promoted angiogenesis, accelerated wound closure, and modulated inflammation both in vitro and in vivo. With comparable results, He et al. [119] encapsulated BNN6, a NO donor, in polymeric NPs and incorporated them in a sodium alginate hydrogel, controlling NO release through near-infrared (NIR) responsive photothermal therapy (PTT). Decreasing inflammation and promoting neoangiogenesis are also key goals of chronic wound treatments. Wu et al. [120] developed a carboxymethyl chitosan and oxidized sodium alginate-based hydrogel loaded with pH-responsive astilbin liposomes and diclofenac sodium for the treatment of diabetic wounds. The hydrogel’s swelling behaviour correlated with the controlled release of both anti-inflammatory drugs in vitro and in vivo, leading to antioxidant and antimicrobial effects, reduced inflammation, enhanced angiogenesis and improved fibrotic wound repair. Chai et al. [121] combined sodium alginate, carboxymethyl chitosan and PVA to incorporate taxifolin, an anti-inflammatory drug and HKUST-1, a copper-based metal-organic framework (MOF) that works as a nano-enzyme. Application of this hydrogel in a diabetic mouse model reduced the levels of inflammatory proteins, such as IL-1β, promoted angiogenesis and re-epithelization, and exhibited antibacterial activity in vitro. Atia et al. [122] aimed to improve the clinical utility of luteolin, another anti-inflammatory drug with poor solubility and limited skin permeation. To achieve this, luteolin was combined with zein, and the resulting nanocomposite was incorporated into a scaffold composed of hyaluronic acid and sodium alginate. In vivo studies in rats demonstrated immune modulation through inhibition of IL-17a secretion and upregulation of IL-13 and VEGF expression. Moreover, miRNA-223 levels were also found to be increased, promoting macrophage polarization into the M2 phenotype. Hosseini et al. [123] created a sodium alginate/carboxymethyl cellulose hydrogel loaded with simvastatin, a drug typically used to reduce lipid levels that has also been associated with angiogenesis promotion and immunomodulation in wound healing. Sustained release of simvastatin for up to 5 days promoted proliferation of fibroblasts and keratinocytes, balanced pro- and anti-inflammatory cytokine profiles in vitro, and resulted in faster wound healing in a rat model. Compared to purely antimicrobial systems, these immunomodulatory approaches address the chronic inflammatory state that often impairs healing, being especially promising, as they target underlying pathological mechanisms rather than just symptoms. In another strategy, Ban et al. [124] produced coacervates of low- and high-molecular-weight cationized gelatin and sodium alginate to encapsulate miR-497, a microRNA that has been previously described by the same authors to exert anti-inflammatory effects in diabetic mice [125]. The coacervates effectively delivered miR-497 to human dermal fibroblasts and keratinocytes, leading to reduced secretion of pro-inflammatory cytokines by the dermal fibroblasts under hyperglycaemic conditions. These findings highlight the potential of this formulation for chronic wound treatment, but further experiments are needed to better characterize its effects in vivo. Liu et al. [126] incorporated polyhexamethylene biguanide, an antiseptic polymer, into sodium alginate hydrogels and then loaded them with glargine insulin. This system showed a strong antibacterial effect, while using insulin as a ‘growth factor-like’ agent promoted macrophage polarization into M2, a more anti-inflammatory phenotype. This resulted in decreased levels of IL-1β, IL-6, INF-γ and TNF-α, together with increased expression of the anti-inflammatory cytokine IL-13. Reconstruction of the epidermal basement membrane was also seen in vivo through Masson’s, keratin 14 and tight junction ZO-1 staining. Growth factors are essential regulators of the healing process, and their incorporation in alginate-based formulations can enhance their stability and improve delivery to wound sites [127]. Therefore, Kuan et al. [128] engineered a bilayered alginate hydrogel for growth factor and cytokine delivery. More precisely, polyelectrolyte complex NPs composed of heparan sulphate and chitosan were conjugated with either VEGF, platelet-derived growth factor (PDGF)-BB, or IL-10. Then, the bottom ionically crosslinked alginate layer was loaded with the IL-10 NPs, whereas the top layer of the alginate, consisting of covalently linked gelatin and alginate, was loaded with the VEGF and PDGF-BB NPs. This way, they obtained a multifunctional biomaterial that could first decrease inflammation, due to faster degradation of the bottom layer and consequent release of IL-10, and later increase angiogenesis mediated by gradual delivery of angiogenic growth factors. Karam et al. [129] also designed NP vehicles for growth factor delivery into chronic wounds using PCL combined with either alginate or alginate sulphate, a heparin-mimicking polymer. These NPs proved to be stable, non-toxic and slowly degradable by lysozymes. By loading them with connective tissue growth factor (CTGF) and applying them to full-thickness excisional wounds in mice, they observed that both NP formulations accelerated the healing, demonstrating their potential for wound treatment. Unfortunately, despite the high effectiveness of growth factor delivery systems, their clinical translation is challenged by issues of cost, stability and regulatory approval. Finally, promoting re-epithelialization is another crucial step for efficient wound closure. With this in mind, Lapmanee et al. [130] incorporated cannabidiol-loaded lipid NPs in a sodium alginate and PVA hydrogel and observed an accelerated wound closure rate in rats, associated with collagen deposition, vascularization and a well-organized epidermal layer. Chen et al. [131] prepared a slow-sculpting hydrogel composed of calcium alginate, graphene oxide and platelet-rich plasma (PRP) that showed high adaptability to irregularly shaped wounds, besides enhancing platelet activity and promoting collagen synthesis and angiogenesis in full-thickness wounds in rats owing to the growth factors present in the PRP. A compilation of the different bioactive molecules embedded in alginate can be found in Table 3. Table 3Compilation of the different bioactive molecules embedded in alginate. Compilation of the different bioactive molecules embedded in alginate. Incorporating bioactive molecules into alginate-based dressings expands therapeutic potential by addressing antimicrobial, anti-inflammatory, angiogenic and regenerative needs. Yet, most studies are limited to short-term or simplified models, making it difficult to predict performance in complex chronic wounds. Moreover, the growing complexity of formulations also challenges reproducibility, manufacturing, and clinical translation. Future work should focus on integrated evaluation of both antimicrobial and regenerative functions under physiologically relevant conditions to ensure that these multifunctional systems provide meaningful and translatable clinical outcomes. Incorporation of cells or cell derivatives Owing to their structural similarity to the ECM of native tissues, alginate hydrogels hold significant potential for cell embedding and delivery to wound sites, as well as for supporting cell migration and proliferation in a 3D environment. These features make alginate-based systems attractive platforms to enhance cell therapy strategies, including for chronic wound treatment [132]. As discussed earlier, macrophages play a central role in wound healing. Although they exhibit a pro-inflammatory (M1) profile during the early stages, facilitating debris clearance and providing antimicrobial activity, a transition toward an anti-inflammatory (M2) phenotype is required during the repair phase to promote angiogenesis, ECM remodelling and resolution of inflammation. In chronic wounds, however, macrophages frequently remain locked in a persistent M1-dominant state, resulting in excessive inflammation and impaired healing [133]. To address this imbalance, Tian et al. [134] embedded pre-polarized M2 macrophages within alginate hydrogels to modulate macrophage behaviour in the wound bed (Figure 5A), building on previously described concepts [21]. The authors demonstrated that alginate sponges were able to preserve the M2 phenotype, as evidenced by the upregulated expression of anti-inflammatory factors such as IL-10, TGF-β and VEGF. Interestingly, although high expression of both the M2 marker Arg-1 and the M1 marker iNOS was detected, suggesting partial phenotypic plasticity, the macrophage-laden sponges still promoted wound healing in type 2 diabetic mice. Nevertheless, the effectiveness of this strategy is limited by macrophage plasticity, as cells may revert to mixed phenotypes in vivo. Therefore, instead of delivering pre-polarized cells, Zhu et al. [135] developed a functional chitosan-based system capable of directing endogenous macrophage polarization into M1 or M2, through modification with either dicyandiamide or PEG. Such an approach could be further enhanced by the incorporation of alginate to improve biomechanical properties and exudate absorption capacity, for example. Schematic figure of some of the different cells and cell derivatives incorporated in alginate, reproduced with permission. (A) Distribution of M2 macrophages within 2% alginate hydrogel [134]. (B) SEM images of exosome-loaded alginate/PCL scaffold. The orange arrows indicate the aggregates of exosomes [153]. (C). Masson stains and SEM images of fresh periosteum and decellularized periosteum [157]. created with ‘BioRender.com’. Fibroblasts represent another central cellular player in wound repair, as they are the most abundant cells in the dermis and the primary producers of ECM components [136, 137]. With that in mind, Gao et al. [138] developed an injectable alginate hydrogel blended with collagen and fibronectin to improve fibroblast embedding and function. The inclusion of these ECM components greatly increased cell spreading and VEGF secretion in vitro, demonstrating the potential of this strategy for wound treatment. In an in vivo study, Oushyani Roudsari et al. [139] incorporated mouse embryonic fibroblasts and copper oxide NPs into alginate microgels using a microfluidic platform. This combinatorial approach resulted in faster wound closure due to synergistic effects that enhanced re-epithelialization, angiogenesis and matrix remodelling. Given their well-known regenerative and immunomodulatory properties, MSCs have also been widely explored for chronic wound applications [140]. MSCs are reported to promote re-epithelialization and angiogenesis, while exerting immunomodulatory and antimicrobial effects, as revised by Nasadiuk et al. [141]. Their accessibility from multiple autologous or allogenic sources, including adipose tissue, dental pulp, Wharton’s jelly, and umbilical cord, and their compatibility with biomaterials and bioactive molecules make MSC-based therapies particularly attractive for chronic wounds [142, 143]. Indeed, MSC therapies have already progressed to clinical evaluation, including in diabetic foot ulcers, where a single application of allogeneic adipose-derived MSCs embedded in a fibrin gel has entered clinical trials (NCT03865394—no results available yet). Fitriani et al. [144] embedded amniotic membrane stem cells (AMSC), a subtype of MSC, within sodium alginate. The constructs proved to be non-toxic to other cells and achieved complete closure in a scratch assay, although in vivo validation remains necessary to fully assess their therapeutic potential. Similarly, Huang et al. [145] incorporated MSCs derived from human perinatal tissues, namely from umbilical cord, chorionic villi, and decidua basalis, into a composite hydrogel of PEGDA, sodium alginate, and collagen I. The authors first characterized the MSCs secretome in vitro, identifying enrichment of ECM-remodelling proteins and involvement of the PI3K/AKT signalling pathway, and subsequently confirmed that MSCs-laden hydrogels enhanced re-epithelialization and neovascularization in vivo. To further potentiate paracrine mechanisms, Lin et al. [146] conditioned MSCs under hypoxic conditions and applied their secretome to neutrophils in vitro, observing suppression of neutrophil extracellular traps (NETs) and ROS production. Building on these findings, hypoxia-conditioned MSCs were encapsulated in an injectable hydrogel composed of sodium alginate and quaternized soy protein isolate grafted with PBA, which enabled on-demand delivery of bioactive factors and resulted in immunomodulation and improved diabetic wound healing in vivo. Despite these promising results, the clinical translation of MSC therapies remains controversial due to variability in isolation protocols and concerns regarding potential malignant transformation [147]. Importantly, many therapeutic effects of MSCs appear to be mediated by secreted paracrine factors rather than direct cell engraftment. These factors are largely packaged within exosomes, a subpopulation of extracellular vesicles (EVs) [148], suggesting that the use of EVs alone may provide safer and more controllable therapeutic alternatives with reduced immunogenicity [149, 150]. In this context, Vakilian et al. [151] isolated MSC-derived EVs and incorporated them into a 3D-printed construct consisting of an alginate core surrounded by a sheath of carboxymethyl cellulose and alginate lyase. The inclusion of the enzyme enabled controlled scaffold degradation, which, in turn, controlled EVs release, while the use of 3D bioprinting provided reproducibility and scalability. Long et al. [152] also incorporated MSC-derived EVs into a sodium alginate hydrogel but combined them with 7A, a 7-amino-acid peptide from histone deacetylase 7 that had previously shown strong angiogenic properties. This combination produced synergistic effects in a diabetic rat model, particularly enhancing fibroblast migration, collagen deposition and angiogenesis. Ashrafi et al. [153] used exosomes derived from human placental MSCs for full-thickness skin wound treatment, but to counteract their rapid clearance, they incorporated them into a bilayer scaffold composed of alginate hydrogel and PCL nanofibers designed to mimic the dermal and epidermal layers of the skin (Figure 5B). This architecture provided sustained exosome release, which in turn promoted collagen synthesis, re-epithelization, and inflammation reduction, ultimately favouring wound closure in vivo. Although alginate hydrogels can support cell proliferation and be combined with bioactive molecules, these strategies only partially recapitulate the complexity of native ECM. An alternative strategy for full tissue regeneration promotion is the use of decellularized matrix (dECM), which preserves native structural and biochemical ECM components, such as collagen fibres, elastin, fibronectin and laminin, in their native architectural structure [154]. This dECM can be blended with alginate and other polymers to improve its biochemical/biophysical properties. For instance, Khosrowpour et al. [155] combined dECM from human placenta with alginate and silk fibroin to fabricate a printable bioink. The resulting 3D constructs supported cell proliferation and, when applied in a mouse model, promoted angiogenesis and re-epithelization without eliciting adverse immune responses. Karmakar et al. [156] produced a hydrogel from amniotic membrane dECM, sodium alginate and carboxymethyl cellulose. This composite proved to have adequate rheological properties, high moisture absorption and improved anti-inflammatory and antibacterial effects. Both Liu et al. [157] and Su et al. [158] developed dressings based on alginate hydrogels combined with periosteum-derived dECM (Figure 5C). While the first authors added nicotinamide mononucleotide to the formulation to boost energy metabolism and reduce oxidative stress, the second group incorporated copper selenide NPs to create a photo-responsive system capable of near-infrared irradiation (NIR)-induced ROS generation for antibacterial purposes. In vitro, both strategies promoted angiogenesis and cell proliferation. In vivo, the first approach additionally demonstrated anti-inflammatory effects and nerve fibre regeneration, whereas the second focused primarily on antibacterial efficacy. Alginate-based hydrogels provide a versatile platform for cell delivery and cell-derived factors, supporting angiogenesis, immunomodulation and tissue regeneration, as summarized in Table 4. Nevertheless, despite promising preclinical results, challenges remain in reproducibility, standardization and long-term safety, particularly for MSC-based therapies due to isolation variability and potential malignant transformation. Since many observed therapeutic effects rely on paracrine signalling rather than direct engraftment, cell-free approaches, such as extracellular vesicles, may offer safer and more controllable alternatives. Alternatively, blending decellularized ECM with alginate proved to be a good strategy to improve biochemical and structural mimicry, promoting re-epithelization. Table 4Summary of the most recent studies incorporating cells and cell derivatives in alginate-based strategies for chronic wound applications.Biomaterials combinedCells or cell derivatives incorporatedMain results/effectsRef.Efficient drug releaseImproved wound closureDecreased inflammationRe-vascularization and re-epithelializationAlginateM2 macrophages X X [134]Alginate, collagen, fibronectinFibroblasts X [138]Alginate, copper oxide NPsMouse embryonic fibroblasts X X [139]AlginateAmniotic membrane stem cells X [144]Alginate, PEGDA, collagen IMSCs X X [145]Alginate, quaternized soy protein isolate, PBAHypoxia-conditioned MSCs X [146]Alginate, carboxymethyl cellulose, alginate lyaseMSC-derived EVs X [151]Alginate, 7AMSC-derived EVs X X [152]Alginate, PCL nanofibersMSC-derived exosomes X X X X [153]Alginate, silk fibroindECM X [155]Alginate, carboxymethyl cellulosedECM X [156]Alginate, nicotinamide mononucleotidedECM X X [157]Alginate, copper selenide NPsdECM X [158]dECM, decellularized extracellular matrix; EV, extracellular vesicles; MSC, mesenchymal stem/stromal cells; NPs, nanoparticles; PBA, aminophenylboronic acid; PCL, polycaprolactone; PEGDA, polyethylene glycol diacrylate. Summary of the most recent studies incorporating cells and cell derivatives in alginate-based strategies for chronic wound applications. dECM, decellularized extracellular matrix; EV, extracellular vesicles; MSC, mesenchymal stem/stromal cells; NPs, nanoparticles; PBA, aminophenylboronic acid; PCL, polycaprolactone; PEGDA, polyethylene glycol diacrylate. Future perspectives Limitations and challenges of alginate-based wound dressings and how to overcome them Despite their widespread clinical use and favourable safety profile, commercially available alginate-based wound dressings still exhibit limited capacity to actively modulate the chronic inflammatory environment. Most current-in-use products primarily function as passive exudate absorbers rather than bioactive regulators of wound healing [29, 159]. However, emerging advances demonstrate that alginate hydrogels can be engineered to incorporate anti-inflammatory, immunomodulatory, and regenerative functionalities, originating ‘next generation’ dressings that can actively resolve persistent inflammation and promote progression toward the proliferative phase of healing, addressing a central pathological barrier in chronic wounds. Although alginate dressings are highly effective in managing exudate, excessive swelling, and limited control over moisture balance can sometimes lead to maceration or hinder cellular infiltration [160]. This highlights the need for more precise tuning of fluid-handling properties. Advances in hydrogel architecture and composite design (e.g. with chitosan or gelatin) allow improved regulation of swelling behaviour and moisture retention, enabling dressings that maintain an optimal moist environment while preserving structural integrity [66, 93]. Such refinements could significantly improve wound bed conditions and support more efficient healing. Mechanical weakness and structural instability also remain important challenges, particularly in dynamic wound environments such as joints or pressure-prone areas. Unmodified alginate hydrogels are often fragile and lack sufficient tensile strength, which can compromise dressing integrity during use [11]. Advances in material design, including polymer blending and optimized crosslinking strategies, have shown that alginate-based systems can be reinforced to achieve improved mechanical robustness without compromising biocompatibility [161, 162]. Looking forward, the development of mechanically adaptive or stimuli-responsive alginate composites could further enhance durability while maintaining flexibility for complex wound sites. Another key limitation of clinically used alginate dressings is their insufficient intrinsic antimicrobial activity, which restricts their effectiveness in managing biofilm-associated infections. While current products can absorb exudate and physically entrap microorganisms, they do not inherently prevent bacterial colonization or biofilm persistence [163]. Advanced strategies focus on transforming alginate dressings into active antimicrobial platforms by incorporating bioactive agents such as antibiotics or antimicrobial peptides (e.g. β-defensin-2). These functionalized systems have demonstrated the ability to disrupt biofilms, enhance bacterial clearance and promote tissue repair, highlighting the shift toward infection-responsive therapeutic materials [164]. Nevertheless, traditional alginate systems often exhibit burst release profiles, which may reduce treatment efficacy. To address this, advanced delivery strategies incorporating nanoparticles, microspheres or multi-layered hydrogel systems have been developed to enable sustained and targeted release of bioactive molecules [165]. These innovations provide a pathway toward multifunctional dressings capable of delivering not only antimicrobial drugs, but also anti-inflammatory and pro-regenerative cues, such as cytokines, growth factors and bioactive peptides, over time. In addition, the lack of intrinsic cell adhesion motifs in alginate limits cellular interaction, which is critical for tissue regeneration and integration [46]. To overcome this limitation, biofunctionalization strategies, like the incorporation of adhesion peptides (e.g. RGD and YIGSR) or ECM components (e.g. collagen and fibronectin), have been explored to enhance cell-material interactions [57]. These approaches offer promising routes to design scaffolds that actively guide cellular behaviour and improve both vascularization and re-epithelialization. In summary, while commercially available alginate-based dressings already provide essential functions such as exudate management and biocompatibility, their transformation into bioactive and multifunctional systems represents a key future direction. As mentioned throughout this review, several strategies have been employed to address the existing limitations, with good results and potential for clinical application. However, future research should focus on integrating these different strategies to develop multifunctional wound dressings that maximize therapeutic outcomes, while also covering the translational aspects, such as scalability and regulatory approval. Future research directions Although many advanced formulations have demonstrated promising results in preclinical studies, their translation to clinical use remains extremely limited. Consistent with this, there appear to be relatively few ongoing or recently completed clinical trials assessing next-generation alginate-based therapies for chronic wound treatment, with most studies remaining limited to post-market surveillance (e.g. NCT05690685), small feasibility trials or incremental modifications such as silver or honey incorporation (e.g. NCT06873646). The successful translation of these advanced systems depends on addressing key manufacturing and regulatory challenges. The incorporation of multiple functional components, such as cells, growth factors or nanoparticles, into alginate-based platforms increases production complexity and cost, potentially limiting widespread adoption. At the same time, regulatory frameworks for combination products and bioactive dressings remain complex, requiring rigorous evaluation of long-term safety, stability, efficacy and quality control, and some framework adjustments may be necessary to better accommodate hybrid biomaterial-biological systems [166]. Standardized preclinical models that more accurately mimic chronic wound pathophysiology are needed to generate meaningful and comparable data across studies. In this context, Ojeh et al. [167] proposed ‘The Wound Reporting in Animal and Human Preclinical Studies (WRAHPS) Guidelines’ to improve transparency and consistency across reports and studies before translation into human clinical trials. Advanced GMP-compatible manufacturing processes should be prioritized early in development to ensure that promising technologies remain feasible for large-scale production and commercialization [168]. Automated 3D printing and continuous fabrication systems can reduce variability and improve reproducibility [89, 155], while integration of artificial intelligence (AI) may contribute to material design and predictive modelling for optimization of alginate formulations. Additionally, AI should be explored for remote wound monitoring in combination with smart dressings that incorporate sensors for oxygen, pH and temperature measurement or even detect bacterial infection [61, 159]. These technologies collectively open the possibility of producing standardized yet customizable wound dressings at scale, bridging the gap between laboratory innovation and real-world clinical application. Still, it is important to note that the underlying pathophysiology of chronic wounds is still not fully understood, and the heterogeneity of chronic wounds complicates clinical study design, perhaps diluting apparent efficacy across diverse patient populations and limiting the commercial attractiveness and viability despite its therapeutic potential [44, 169]. Therefore, future research should maintain focus on the synergistic integration of different functional components, such as bioactive molecules and composite systems, with technology advances (e.g. AI, 3D-bioprinting), while also dedicating resources to fundamental investigation on chronic wounds pathophysiology, in order to generate multifunctional wound dressings capable of actively modulating the complex wound healing cascade. Conclusion Chronic wounds continue to represent a profound clinical and socioeconomic problem worldwide, affecting millions of patients and contributing substantially to healthcare and expenditure costs due to prolonged treatment, frequent amputations and productivity losses [27]. Moreover, as the global burden of chronic wounds continues to rise with ageing populations and increasing prevalence of diabetes and vascular disease, the need for more effective therapies becomes increasingly urgent. Alginate-based dressings that are commercially available and currently in use in the clinic offer valuable benefits, primarily related to exudate management, haemostasis and provision of a moist healing environment, but fail to address key pathophysiological drivers of chronicity, including persistent inflammation, microbial infection, oxidative stress and impaired tissue repair [2, 23]. Over the past decade, extensive research has focused on converting alginate from a largely passive, absorbent dressing to an active therapeutic platform, changing the paradigm of wound dressings. Multiple strategies have been pursued, ranging from advanced alginate-based formulations, such as nanoparticles, aerogels and microneedles, to composite systems with complementary polymers, together with the incorporation of antimicrobial agents, growth factors, stem cells and cell-derived vesicles. These approaches have shown promising improvements in modulating the wound microenvironment, tissue integration, antimicrobial efficacy, mechanical performance and controlled delivery. Nevertheless, despite excellent in vitro and in vivo results across many studies, the vast majority of these advanced formulations have not progressed to clinical translation [44]. By integrating advanced design technologies with scalable manufacturing and prioritizing robust clinical validation, cost-effectiveness analyses and clear regulatory strategies, alginate-based biomaterials can move closer to becoming widely adopted, next-generation solutions for chronic wound management. Realizing this potential will require strategic innovation focused on translational feasibility, ultimately enabling advanced alginate-based solutions to move from experimental promise to clinical reality. Contributor Information Eduarda Pinto, I3S—Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto 4200-125, Portugal; INEB—Instituto de Engenharia Biomédica, Porto 4200-125, Portugal; ICBAS—Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Porto 4050-313, Portugal. Cristina C Barrias, I3S—Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto 4200-125, Portugal; INEB—Instituto de Engenharia Biomédica, Porto 4200-125, Portugal; ICBAS—Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Porto 4050-313, Portugal. Judite Novais Barbosa, I3S—Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto 4200-125, Portugal; INEB—Instituto de Engenharia Biomédica, Porto 4200-125, Portugal; ICBAS—Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Porto 4050-313, Portugal. Funding This work was supported by the Fundo Europeu de Desenvolvimento Regional (FEDER) and national funds related to the operation no. [16784], operation code [COMPETE2030-FEDER-00796700], under the Call for Applications no. [MPr-2023-12] (DOI: https://doi.org/10.54499/2023.18474.ICDT). Conflicts of interest There are no conflict of interests or disclosures to declare. References